Outcome Health, which equips providers with screens displaying educational content, has added its first chief engineering officer to its ranks. Nandini Ramani, who most recently served as VP of Engineering at Twitter, will assume the post.
"Healthcare is an industry close to my heart and Outcome Health's impact on society is tangible and meaningful," Ramani said in a statement. "In addition to Outcome Health's commitment to its mission, the addressable market and track record of growth are remarkable. Building a platform that can deliver better decision making, clinical workflow and health outcomes is a rare opportunity, especially at this scale."
Healthcare software development company XchangeLabs has a new CEO as of earlier this month. Joel Becker, who most recently served as President of the Americas Division at St. Jude's Medical, will lead the company.
“Joel is the right leader for XchangeLabs,” Stewart Stephens, XchangeLabs’ chief technical officer and Chairman of the Board, said in a statement. “Joel’s extensive healthcare background and business development skills will help XchangeLabs develop strategic alliances, strengthen channel partnerships, and expand our presence in the healthcare technology space.”
Vital signs monitoring company EarlySense, which has recently begun to expand its provider-facing business, has hired Dr. Michael DeVita as its new Chief Medical Officer. An MD of 30 years' experience, DeVita most recently served as medical director of critical care medicine at Harlem Hospital in New York City.
“We are proud to welcome Dr. DeVita as our Chief Medical Officer," CEO Avner Halperin said in a statement. "EarlySense has emerged as the market leader for contact-free continuous monitoring solutions, and Dr. DeVita’s knowledge and expertise will help support our medical innovation as we continue on our upward growth path."
Deirdre Bavard is the new chief operating officer at Elligo Health Research, a clinical research software company. Bavard recently held the post of VP of development at Nektar Therapeutics.
“BeVard’s experience and passion for creating clinical trial efficiencies perfectly align with our core mission,” CEO John Potthoff said in a statement. “Through her analysis and fostering of productive stakeholder relationships, she will create environments that enhance the clinical trial process for sponsors, physicians and patients.”
PreparedHealth, which makes the Entouch mobile and desktop system for connecting patients, providers, and other stakeholders, has tapped Iqbal Brainch as its new chief marketing officer. Brainch was most recently VP of marketing and product strategy for OptionsCity, a software company in the financial space.
“Having Iqbal join the team marks a major milestone for our company," Ashish V. Shah, CEO and founder of PreparedHealth, said in a statement. "We have deliberately prioritized understanding the problems within post acute care, crafting a delightful product experience and establishing a responsive service-oriented culture that delivers great client outcomes. With all of these foundational aspects of our culture in place, we are ready to formally accelerate our marketing efforts to expand our reach nationally."
Gian Cavallini, VP of Strategy and Development at Advanced ICU Care, has been named chair of the American Telemedicine Association's Industry Council. The council is one of two primary member groups at ATA and includes corporations that are not hospitals or health systems.
"I'm excited and honored to be part of the ATA Industry Council’s mission to drive telehealth innovation and adoption with the goal of improving the quality and accessibility of healthcare globally,” Cavallini said in a statement.
ResApp, an Australian company working on algorithms to detect respiratory diseases via the phone's microphone, has added a new face to its Scientific Advisory Board. Dr. Philip Currie, a cardiologist of 35 years experience, including stints at the Mayo Clinic and the Cleveland Clinic.
“I am delighted that Dr. Currie is joining our Scientific Advisory Board,” CEO Tony Keating said in a statement. “His extensive experience in medical research at leading US hospitals will provide us with invaluable clinical expertise as we move forward with pediatric and adult clinical studies in the US this winter.”